Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8000
+0.0200 (2.56%)
May 28, 2025, 2:12 PM EDT

Interpace Biosciences Statistics

Total Valuation

IDXG has a market cap or net worth of 3.45 million. The enterprise value is 6.49 million.

Market Cap 3.45M
Enterprise Value 6.49M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date Aug 11, 2025
Ex-Dividend Date n/a

Share Statistics

IDXG has 4.42 million shares outstanding. The number of shares has increased by 391.99% in one year.

Current Share Class 4.42M
Shares Outstanding 4.42M
Shares Change (YoY) +391.99%
Shares Change (QoQ) -44.28%
Owned by Insiders (%) 21.85%
Owned by Institutions (%) 3.25%
Float 3.46M

Valuation Ratios

The trailing PE ratio is 2.31.

PE Ratio 2.31
Forward PE n/a
PS Ratio 0.07
PB Ratio -5.93
P/TBV Ratio n/a
P/FCF Ratio 0.68
P/OCF Ratio 0.58
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.66, with an EV/FCF ratio of 1.28.

EV / Earnings 0.90
EV / Sales 0.13
EV / EBITDA 0.66
EV / EBIT 0.74
EV / FCF 1.28

Financial Position

The company has a current ratio of 1.34

Current Ratio 1.34
Quick Ratio 1.15
Debt / Equity n/a
Debt / EBITDA 0.43
Debt / FCF 0.83
Interest Coverage 16.93

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 41.41%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 151.70%
Revenue Per Employee 434,802
Profits Per Employee 64,658
Employee Count 111
Asset Turnover 3.62
Inventory Turnover 14.62

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.30% in the last 52 weeks. The beta is 0.69, so IDXG's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change -47.30%
50-Day Moving Average 0.95
200-Day Moving Average 1.70
Relative Strength Index (RSI) 44.06
Average Volume (20 Days) 7,842

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.32

Income Statement

In the last 12 months, IDXG had revenue of 48.26 million and earned 7.18 million in profits. Earnings per share was 0.33.

Revenue 48.26M
Gross Profit 30.98M
Operating Income 8.82M
Pretax Income 7.91M
Net Income 7.18M
EBITDA 9.17M
EBIT 8.82M
Earnings Per Share (EPS) 0.33
Full Income Statement

Balance Sheet

The company has 1.20 million in cash and 4.24 million in debt, giving a net cash position of -3.04 million or -0.69 per share.

Cash & Cash Equivalents 1.20M
Total Debt 4.24M
Net Cash -3.04M
Net Cash Per Share -0.69
Equity (Book Value) -582,000
Book Value Per Share -0.13
Working Capital 2.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.94 million and capital expenditures -848,000, giving a free cash flow of 5.09 million.

Operating Cash Flow 5.94M
Capital Expenditures -848,000
Free Cash Flow 5.09M
FCF Per Share 1.15
Full Cash Flow Statement

Margins

Gross margin is 64.20%, with operating and profit margins of 18.28% and 15.83%.

Gross Margin 64.20%
Operating Margin 18.28%
Pretax Margin 16.38%
Profit Margin 15.83%
EBITDA Margin 18.99%
EBIT Margin 18.28%
FCF Margin 10.55%

Dividends & Yields

IDXG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -391.99%
Shareholder Yield n/a
Earnings Yield 208.03%
FCF Yield 147.56%

Stock Splits

The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.

Last Split Date Jan 15, 2020
Split Type Reverse
Split Ratio 0.1

Scores

IDXG has an Altman Z-Score of -16.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.69
Piotroski F-Score n/a